The Opportunity Provided by Vaccination Offer to Refugees from Ukraine in European Countries.

equity immunisation refugees from Ukraine temporary protection vaccination offer vaccine vaccine-preventable diseases

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
28 May 2024
Historique:
received: 10 04 2024
revised: 22 05 2024
accepted: 25 05 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

(1) The Russian invasion of Ukraine forced many people to leave their country and seek asylum in various European countries, with serious consequences from a health perspective. In this context, we describe the health measures undertaken by AcToVax4NAM Consortium Countries (Cyprus-Germany-Greece-Italy-Malta-Poland-Romania-Spain) to prevent Vaccine-Preventable Disease (VPD) outbreaks in the context of mass movements of populations that resulted from the crisis in Ukraine. (2) We collected information on the vaccinations offered to Ukrainians in the Consortium Countries. (3) All these countries have provided Temporary Protection (TP) status to refugees from Ukraine and have followed the recommendations of European and International Agencies to offer them vaccinations according to the National Immunisation Programmes. The COVID-19 vaccination is offered in all countries with regard to the general population. Most countries provide information on TP and access to health/vaccination services in the Ukrainian language. (4) The information collected shows a common effort to ensure the adequate planning of health and vaccination services for refugees from Ukraine and, very often, to include them in the national vaccination offer. It is important that this initial response towards people who have fled Ukraine will be continued following the emergency but, more importantly, that it serves as a best practice towards all migrants and refugees entering the EU.

Identifiants

pubmed: 38932318
pii: vaccines12060589
doi: 10.3390/vaccines12060589
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : AcToVax4NAM (Access to Vaccination for Newly Arrived Migrants) is a project co-funded by the European Union's 3rd Health Programme (2014-2020)
ID : 101018349

Auteurs

Giulia Marchetti (G)

National Center for Global Health, Istituto Superiore di Sanità, 00161 Rome, Italy.

Franca D'Angelo (F)

National Center for Global Health, Istituto Superiore di Sanità, 00161 Rome, Italy.

Caterina Ferrari (C)

Department of Public Health and Infectious Diseases, Sapienza Università di Roma, 00185 Rome, Italy.

Arianna Bellini (A)

Department of Public Health and Infectious Diseases, Sapienza Università di Roma, 00185 Rome, Italy.

Marise Sabato (M)

Department of Public Health and Infectious Diseases, Sapienza Università di Roma, 00185 Rome, Italy.

Salvatore Scarso (S)

National Center for Global Health, Istituto Superiore di Sanità, 00161 Rome, Italy.
Department of Public Health and Infectious Diseases, Sapienza Università di Roma, 00185 Rome, Italy.

Pania Karnaki (P)

Prolepsis Institute, 151 25 Athens, Greece.

Maurizio Marceca (M)

Department of Public Health and Infectious Diseases, Sapienza Università di Roma, 00185 Rome, Italy.

Maria Laura Russo (ML)

Department of Public Health and Infectious Diseases, Sapienza Università di Roma, 00185 Rome, Italy.

Maria Elena Tosti (ME)

National Center for Global Health, Istituto Superiore di Sanità, 00161 Rome, Italy.

Silvia Declich (S)

National Center for Global Health, Istituto Superiore di Sanità, 00161 Rome, Italy.

Classifications MeSH